Novo Nordisk - Regulatory Approval (December 2025): FDA approved the first oral GLP-1 for weight loss-Novo Nordisk's once-daily semaglutide pill-which launched in January 2026 [3]
Here's the honest version what it is, how it's thought to work, what the science supports, and where it realistically fits
9,10 The cGSTs are divided into seven subtypes according to similarities in amino-acid sequence, different structure of genes, and immunological cross-reactivity
The ASIP gene helps regulate this system by influencing how strongly melanocortin receptors respond, which can affect the balance of darker, more UV-protective pigment and lighter pigment with less protection
No differences were observed in the sex proportions, age or anthropometrical values between the subjects in the MO and PLC groups
doi: 10.1152/ajpendo.00347.2016